Treatment of the AML cells from patients with post-transplant relapse with interferon-gamma, a cytokine known to increase expression of HLA class II genes, was able to increase the number of class II molecules on cell surfaces of AML cells as assessed by flow cytometry. Here, IFNG is linked to acute myeloid leukemia.